Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen B Riggs

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
World Journal of Urology|September 22, 2014
Nutritional predictors of complications following radical cystectomyDavid C Johnson, Stephen B Riggs, Matthew E Nielsen, et al.
Urologic Oncology|May 12, 2024
It's complicated: The relationship of non-narcotic medications and postoperative opioid use in radical cystectomy patientsSamuel J Ivan, Emily H Roebuck, Alexander L Sinks, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 26, 2009
Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomyTobias Klatte, David B Seligson, Jeffrey LaRochelle, et al.
Urology Practice|June 20, 2024
Reply by AuthorsAlexander L Sinks, Hailey W Holck, Lila G McGrath, et al.
Urology Practice|June 20, 2024
Impact of Socioeconomic Status on Patient Adherence in Managing Renal MassesAlexander L Sinks, Hailey W Holck, Lila G McGrath, et al.
The Journal of Urology|November 13, 2007
The chemokine receptor CXCR3 is an independent prognostic factor in patients with localized clear cell renal cell carcinomaTobias Klatte, David B Seligson, John T Leppert, et al.
Urologic Oncology|June 25, 2022
Impact of dedicated renal enhanced recovery after surgery (RERAS) program on postoperative opioid consumption and evaluation of surgeon-specific compliance to the programEmily H Roebuck, Samuel J Ivan, Myra M Robinson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinomaTobias Klatte, David B Seligson, Stephen B Riggs, et al.
Clinical Genitourinary Cancer|May 17, 2022
Testis Cancer Care in North Carolina: Implications for Real-World Evidence and Cancer SurveillanceStephen McMahon, Xi Zhou, Christopher D Baggett, et al.
Urology Practice|May 5, 2023
Association of 5-Alpha Reductase Inhibitor Use with Prostate Specific Antigen Level at the Time of Urology Referral in a Retrospective Cohort at a Large, Integrated Health Care SystemJames T Kearns, Justin T Matulay, William E Anderson, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
World Journal of Urology|September 22, 2014
Nutritional predictors of complications following radical cystectomyDavid C Johnson, Stephen B Riggs, Matthew E Nielsen, et al.
Urologic Oncology|May 12, 2024
It's complicated: The relationship of non-narcotic medications and postoperative opioid use in radical cystectomy patientsSamuel J Ivan, Emily H Roebuck, Alexander L Sinks, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 26, 2009
Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomyTobias Klatte, David B Seligson, Jeffrey LaRochelle, et al.
Urology Practice|June 20, 2024
Reply by AuthorsAlexander L Sinks, Hailey W Holck, Lila G McGrath, et al.
Urology Practice|June 20, 2024
Impact of Socioeconomic Status on Patient Adherence in Managing Renal MassesAlexander L Sinks, Hailey W Holck, Lila G McGrath, et al.
The Journal of Urology|November 13, 2007
The chemokine receptor CXCR3 is an independent prognostic factor in patients with localized clear cell renal cell carcinomaTobias Klatte, David B Seligson, John T Leppert, et al.
Urologic Oncology|June 25, 2022
Impact of dedicated renal enhanced recovery after surgery (RERAS) program on postoperative opioid consumption and evaluation of surgeon-specific compliance to the programEmily H Roebuck, Samuel J Ivan, Myra M Robinson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinomaTobias Klatte, David B Seligson, Stephen B Riggs, et al.
Clinical Genitourinary Cancer|May 17, 2022
Testis Cancer Care in North Carolina: Implications for Real-World Evidence and Cancer SurveillanceStephen McMahon, Xi Zhou, Christopher D Baggett, et al.
Urology Practice|May 5, 2023
Association of 5-Alpha Reductase Inhibitor Use with Prostate Specific Antigen Level at the Time of Urology Referral in a Retrospective Cohort at a Large, Integrated Health Care SystemJames T Kearns, Justin T Matulay, William E Anderson, et al.
Pageof 4